OPT 3.90% 40.0¢ opthea limited

Ann: Opthea Completes Placement & Institutional Entitlement Offer, page-32

  1. 7 Posts.
    lightbulb Created with Sketch. 3
    If there is clinical success the SP will go way above $1. I wouldn't be stuffed full of 80c options if I thought that. Pfizer sell US$10b of Eylea peryear and sozinibercept combo will eclipse all comers. Why woudln't Pfizer pay OPT US$1b per year to add a sozinibercept to each treatment and stay ahead of the pack? Do the math on US$1b per year profit. At PE of 10 that US$10b = $16? Not saying that will happen but there's the ball park.
 
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.015(3.90%)
Mkt cap ! $486.2M
Open High Low Value Volume
39.0¢ 40.5¢ 38.5¢ $300.8K 758.6K

Buyers (Bids)

No. Vol. Price($)
25 90549 39.5¢
 

Sellers (Offers)

Price($) Vol. No.
40.0¢ 30458 8
View Market Depth
Last trade - 12.52pm 24/07/2024 (20 minute delay) ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.